Takeda — Drug Prices & Medicare Spending

Takeda manufactures 18 drugs tracked by Medicare Part D with total spending of $8.1B.

Drugs Tracked

$8.1B

Medicare Spending

$249.24

Avg Cost/Claim

94%

Have Generics

Takeda Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Entyvio	Vedolizumab	$6,319.00	$1.6B	+14.6%	Yes
2	Vyvanse	Lisdexamfetamine	$238.00	$1.3B	-18.4%	Yes
3	Trintellix	Vortioxetine	$278.00	$1.1B	+7.8%	No
4	Ninlaro	Ixazomib	$7,884.00	$678.0M	-4.5%	Yes
5	Advate	Antihemophilic Factor (rDNA)	$25,333.00	$456.0M	-14.6%	Yes
6	Mydayis	Mixed Amphetamine Salts ER	$205.00	$345.0M	+12.4%	Yes
7	Dexilant	Dexlansoprazole	$139.00	$345.0M	-14.2%	Yes
8	Colcrys	Colchicine	$139.00	$345.0M	-14.6%	Yes
9	Velcade	Bortezomib	$5,074.00	$345.0M	-22.4%	Yes
10	Adynovate	Antihemophilic Factor (PEG)	$24,643.00	$345.0M	-6.2%	Yes
11	Uloric	Febuxostat	$126.00	$234.0M	-28.4%	Yes
12	Intuniv	Guanfacine ER	$144.00	$178.0M	-22.4%	Yes
13	Motegrity	Prucalopride	$206.00	$178.0M	+22.4%	Yes
14	Edarbi	Azilsartan	$144.00	$178.0M	-8.4%	Yes
15	Actos	Pioglitazone	$30.00	$145.0M	-28.4%	Yes
16	Prevacid	Lansoprazole	$50.00	$123.0M	-34.2%	Yes
17	Nesina	Alogliptin	$142.00	$123.0M	-14.6%	Yes
18	Pioglitazone	Pioglitazone	$36.00	$89.0M	-28.4%	Yes

Takeda manufactures 18 drugs tracked by Medicare Part D, with total annual spending of $8.1B.

Advate (Antihemophilic Factor (rDNA)) is the most expensive at $25,333.00 per claim.

17 of 18 Takeda drugs (94%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.